Get the Stockscreener App
0.00
100.00%
-0.157
After Hours:
.15
0.15
+
Glycomimetics Inc stock is traded at $0.00, with a volume of 0.
It is down -100.00% in the last 24 hours and down -100.00% over the past month.
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.
See More
Previous Close:
$0.157
Open:
$0
24h Volume:
0
Relative Volume:
0.00
Market Cap:
$11.00M
Revenue:
$1.16M
Net Income/Loss:
$-39.74M
P/E Ratio:
0.00
EPS:
-0.62
Net Cash Flow:
$-35.02M
1W Performance:
-100.00%
1M Performance:
-100.00%
6M Performance:
-100.00%
1Y Performance:
-100.00%
1-Day Range:
$0.00
$0.00
1-Week Range:
$0.00
$0.00
52-Week Range:
$0.00
$0.4477
Glycomimetics Inc Stock (GLYC) Company Profile
Name
Glycomimetics Inc
Sector
Industry
Phone
240-243-1201
Address
9708 MEDICAL CENTER DRIVE, ROCKVILLE, MD
Compare GLYC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GLYC
Glycomimetics Inc
|
0.00 | 11.00M | 1.16M | -39.74M | -35.02M | -0.62 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Glycomimetics Inc Stock (GLYC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-25-25 | Initiated | Jefferies | Buy |
| Aug-11-25 | Initiated | H.C. Wainwright | Buy |
| Jul-14-25 | Initiated | Wedbush | Outperform |
| Jun-25-25 | Initiated | Stifel | Buy |
| Mar-21-25 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-26-24 | Downgrade | TD Cowen | Buy → Hold |
| Dec-22-23 | Initiated | CapitalOne | Overweight |
| Nov-12-21 | Upgrade | Jefferies | Hold → Buy |
| Nov-14-19 | Initiated | ROTH Capital | Buy |
| Aug-05-19 | Downgrade | Jefferies | Buy → Hold |
| Aug-05-19 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Aug-05-19 | Downgrade | SunTrust | Buy → Hold |
| Apr-12-19 | Initiated | Piper Jaffray | Overweight |
| Dec-18-18 | Initiated | H.C. Wainwright | Buy |
| Jul-26-16 | Initiated | SunTrust | Buy |
| Mar-17-15 | Reiterated | Stifel | Buy |
View All
Glycomimetics Inc Stock (GLYC) Latest News
Identifying reversal signals in GlycoMimetics Inc.July 2025 Earnings & Low Risk Entry Point Guides - newser.com
GlycoMimetics Inc. stock prediction for this weekEarnings Summary Report & Daily Oversold Stock Bounce Ideas - newser.com
Long term hold vs stop loss in GlycoMimetics Inc.July 2025 Intraday Action & Daily Stock Trend Reports - newser.com
Predicting GlycoMimetics Inc. trend using moving averages2025 Retail Activity & Reliable Trade Execution Plans - newser.com
How interest rate cuts could boost GlycoMimetics Inc. stock2025 Volatility Report & Weekly Consistent Profit Watchlists - newser.com
How to forecast GlycoMimetics Inc. trends using time series2025 Bull vs Bear & Verified Entry Point Signals - newser.com
What machine learning models say about GlycoMimetics Inc.Market Risk Analysis & Safe Entry Zone Tips - newser.com
Best data tools to analyze GlycoMimetics Inc. stockTrade Signal Summary & Growth Oriented Trading Recommendations - newser.com
Why GlycoMimetics Inc. stock remains undervaluedGap Down & Stock Timing and Entry Methods - newser.com
Real time pattern detection on GlycoMimetics Inc. stockWeekly Trend Recap & High Accuracy Swing Trade Signals - newser.com
Earnings visualization tools for GlycoMimetics Inc.2025 Geopolitical Influence & Real-Time Chart Pattern Alerts - newser.com
Is GlycoMimetics Inc. stock attractive for growth ETFs2025 Investor Takeaways & Verified Trade Idea Suggestions - newser.com
Published on: 2025-10-31 00:29:32 - newser.com
How GlycoMimetics Inc. stock compares to growth peers2025 Growth vs Value & Step-by-Step Swing Trade Plans - fcp.pa.gov.br
Published on: 2025-10-27 20:15:28 - newser.com
Can GlycoMimetics Inc. stock deliver surprise earnings beatMarket Risk Analysis & Reliable Price Breakout Alerts - Fundação Cultural do Pará
Glycomimetics Inc Stock (GLYC) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):